RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994.

RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994.

Show other versions (30)
Saved in:
Bibliographic Details
Corporate Author: United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology
Format: Government Document Electronic eBook
Language:English
Published: Washington : U.S. G.P.O., 1994.
Series:ProQuest Congressional.
Subjects:
Mifepristone > Government policy > United States.
Progesterone > Antagonists > Government policy > United States.
Pharmaceutical policy > United States.
Online Access:Connect to this title via ProQuest
Description
Item Description:Record is based on bibliographic data in LexisNexis Congressional Hearings Digital Collection. Reuse except for individual research requires license from LexisNexis Academic & Library Solutions.
Physical Description:iii, 48 p. ; 24 cm.
Format:System requirements: PDF reader software.
Bibliography:Includes bibliographical references (p. 46).

Similar Items